Stocks & ETFs Screener: 200+ results (Biotechnology)

Symbol	Industry	Market Cap	Fund. Score	Div. Score	Tech. Score	P/E	Return 12m vs S&P 500
ABBV AbbVie	Biotechnology Biologics, Immunology, Oncology	403B	55.6%	70.4%	85.4%	109	-1.20%
AMGN Amgen	Biotechnology Rheumatoid Arthritis, Psoriasis	159B	80.8%	68.8%	34.4%	23.9	-19.4%
GILD Gilead Sciences	Biotechnology Antivirals, Oncology, Hepatitis	150B	78.6%	61.7%	87.5%	24.0	16.4%
VRTX Vertex	Biotechnology Cystic Fibrosis, Sickle Cell, Beta	108B	86.4%	-	19.7%	30.0	-25.5%
REGN Regeneron	Biotechnology Eylea, Dupixent, Libtayo	62.0B	79.3%	13.5%	-28.9%	14.5	-40.0%
ALNY Alnylam	Biotechnology RNAi Therapeutics, Patisiran	60.7B	33.2%	-	84.3%	-	34.6%
ARGX argenx	Biotechnology Antibody,Autoimmune,Therapy,FcRn,Ig..	50.4B	68.8%	-	76.0%	41.7	25.3%
HLN Haleon	Biotechnology Toothpaste, Vitamins, Pain-Relief	41.8B	52.7%	53.5%	49.2%	20.6	-19.6%
ONC BeiGene	Biotechnology BTK-Inhibitor, Anti-PD-1	35.8B	56.1%	-	57.1%	-	26.1%
INSM Insmed	Biotechnology Inhaled Antibiotic, DPP1	35.3B	38.0%	-	81.8%	-	133%
22UA BioNTech SE	Biotechnology Cancer Vaccines, mRNA Therapies	25.6B	12.8%	1.0%	-57.9%	-	-26.8%
NTRA Natera	Biotechnology Prenatal Screening, Carrier	24.9B	47.6%	-	64.9%	-	28.5%
BNTX BioNTech SE	Biotechnology Oncology Vaccines,Checkpoint	24.9B	13.8%	1.0%	-43.3%	-	-22.6%
BIIB Biogen	Biotechnology Multiple Sclerosis Therapies	22.0B	65.5%	-	-61.1%	14.3	-30.4%
GMAB Genmab AS	Biotechnology Antibody, Cancer, Lymphoma	20.4B	85.8%	-	-7.24%	17.2	7.07%
UTHR United Therapeutics	Biotechnology Treprostinil, Treprostinil	18.9B	85.7%	-	57.9%	16.3	5.78%
INCY Incyte	Biotechnology JAKAFI, MONJUVI, PEMAZYRE	18.2B	87.5%	-	18.6%	21.6	5.57%
BIM Biomerieux	Biotechnology Diagnostic, Instruments, Reagents	15.6B	80.3%	61.1%	35.7%	35.7	-11.8%
SMMT Summit Therapeutics	Biotechnology Antibody, Immunotherapy, Oncology	14.5B	45.6%	-	61.5%	-	-15.8%
NBIX Neurocrine	Biotechnology Movement, Endocrine	14.3B	81.1%	-	34.5%	42.6	-6.41%
ERF Eurofins	Biotechnology Testing, Laboratory, Services	13.0B	68.2%	2.66%	15.8%	27.7	15.1%
ASND Ascendis Pharma AS	Biotechnology Growth Hormone	12.2B	32.9%	-	72.2%	-	39.8%
EXAS EXACT Sciences	Biotechnology Colon, Breast, Biomarker, Tumor	12.0B	45.3%	-	12.4%	-	-24.4%
ROIV Roivant Sciences	Biotechnology Antibody, Inhibitor, Activator	11.8B	29.8%	-	73.9%	-	40.1%
IONS Ionis	Biotechnology Triglyceride,Neuromuscular,ADS,ATTR..	11.3B	26.4%	0.21%	55.7%	-	59.2%
EXEL Exelixis	Biotechnology Cabozantinib, Cobimetinib	10.8B	94.3%	-	79.4%	18.6	1.18%
BMRN Biomarin	Biotechnology Enzyme replacement therapy	10.5B	83.7%	-	-62.6%	16.1	-34.4%
BBIO BridgeBio Pharma	Biotechnology Attruby, Infigratinib, Encaleret	10.4B	46.6%	-	78.1%	-	125%
RVMD Revolution	Biotechnology Targeted Therapies, RAS	10.1B	29.2%	-	43.2%	-	-1.74%
MRNA Moderna	Biotechnology Respiratory Vaccines, Latent	9.90B	25.0%	-	-84.4%	-	-56.7%
MDGL Madrigal	Biotechnology Rezdiffra, MASH, Thyroid, Agonist	9.57B	49.0%	-	77.5%	-	66.9%
GRFS Grifols	Biotechnology Immunoglobulin, Albumin, Clotting	8.00B	65.3%	41.6%	27.3%	18.6	-10.5%
RGC Regencell	Biotechnology TCM,Neurocognitive,ADHD,Autism,Herb..	7.92B	36.4%	-	74.5%	-	7,481%
HALO Halozyme	Biotechnology Hyaluronidase Enzyme, Hylenex	7.74B	86.3%	-	53.9%	15.1	7.68%
CYTK Cytokinetics	Biotechnology Omecamtiv, Aficamten, CK089, CK586	7.42B	32.1%	-	36.5%	-	2.26%
RYTM Rhythm	Biotechnology IMCIVREE, Obesity-Drug	7.34B	49.2%	-	90.0%	-	90.2%
ABVX Abivax American	Biotechnology Hepatitis,HIV,Autoimmune,Infection	7.21B	38.5%	-	65.3%	-	738%
MRUS Merus BV	Biotechnology Bispecific,Antibodies,Cancer,Clinic..	7.19B	33.4%	-	87.1%	-	56.3%
ABVX Abivax	Biotechnology Drug, Phase3, Ulcerative, Crohns	7.16B	38.7%	-	54.7%	-	682%
RNA Avidity Biosciences	Biotechnology Antibody, Oligonucleotide	6.99B	32.2%	-	66.2%	-	35.9%
NUVL Nuvalent	Biotechnology ROS1 Inhibitor, ALK Inhibitor	6.67B	28.7%	-	60.6%	-	-8.30%
LEGN Legend Biotech	Biotechnology CAR-T, BCMA, Gamma-Delta	6.07B	32.2%	-	-38.7%	-	-38.6%
CRSP Crispr Therapeutics	Biotechnology Beta Thalassemia Therapy, Sickle	5.69B	25.8%	-	15.5%	-	7.45%
PCVX Vaxcyte	Biotechnology Pneumonia Vaccine, Strep Vaccine	5.50B	30.7%	-	-16.9%	-	-64.5%
TGTX TG Therapeutics	Biotechnology Briumvi, Ublituximab, TG-1701	5.36B	66.7%	-	55.5%	88.9	14.1%
KRYS Krystal Biotech	Biotechnology VYJUVEK, Gene Therapies	5.36B	82.6%	-	51.0%	37.6	-9.20%
PTCT PTC Therapeutics	Biotechnology Translarna, Emflaza, Upstaza	5.31B	79.9%	-	56.4%	9.47	41.2%
ARWR Arrowhead	Biotechnology Arrowhead, siRNA, Therapy, Liver	5.09B	34.9%	-	1.68%	-	80.9%
ALKS Alkermes	Biotechnology Schizophrenia, Bipolar, Alcohol	4.96B	87.1%	-	30.4%	14.5	-1.26%
PRAX Praxis Precision	Biotechnology Cns Therapies, Epilepsy Treatments	4.87B	33.4%	-	31.3%	-	142%
ACLX Arcellx	Biotechnology Anitocabtagene, ACLX-001	4.82B	37.4%	-	58.8%	-	-15.0%
PTGX Protagonist	Biotechnology Inject, Hepcidin, Mimetic	4.66B	52.1%	-	83.8%	103	37.8%
KYMR Kymera Therapeutics	Biotechnology IRAK4 Program,STAT6 Program,TYK2	4.43B	29.4%	-	42.6%	-	8.64%
AKRO Akero Therapeutics	Biotechnology Efruxifermin, EFX, MASH Treatment	4.32B	30.8%	-	49.4%	-	49.0%
MTSR Metsera, Common	Biotechnology Injectable, Oral, Peptides	4.12B	47.9%	-	88.4%	-	212%
NAMS NewAmsterdam	Biotechnology Cholesterol, Lowering, Medicine	4.02B	37.2%	-	75.1%	-	81.3%
CRNX Crinetics	Biotechnology Paltusotine, Atumelnant, CRN09682	3.91B	28.9%	-	28.7%	-	-34.6%
VKTX Viking Therapeutics	Biotechnology Drugs, Liver, Diabetes, Obesity	3.83B	28.9%	-	31.8%	-	-55.2%
APLS Apellis	Biotechnology Empaveli, Syfovre, Geographical	3.76B	39.3%	-	-63.9%	-	-36.9%
QURE Uniqure	Biotechnology Gene Therapy, Hemophilia Treatment	3.76B	42.2%	-	44.6%	-	807%
ACAD ACADIA	Biotechnology Pimavanserin, Trofinetide	3.67B	66.1%	-	46.4%	16.3	29.8%
APGE Apogee	Biotechnology Cystic Fibrosis,’Atopic	3.62B	48.5%	-	41.6%	-	-14.0%
LGND Ligand	Biotechnology Antiviral,Oncology,Vaccine,Respirat..	3.54B	36.4%	0.14%	76.0%	-	43.6%
MIRM Mirum	Biotechnology LIVMARLI, Cholbam, Chenodal	3.52B	43.1%	-	91.3%	-	55.3%
SLNO Soleno Therapeutics	Biotechnology Diazoxide, Choline, Prader-Willi	3.48B	51.6%	-	77.0%	-	4.80%
ADMA ADMA Biologics	Biotechnology Immune Globulin, Hepatitis B	3.43B	85.0%	-	42.7%	16.9	-24.1%
XENE Xenon	Biotechnology Seizure Drugs, Pain Drugs	3.32B	37.1%	-	12.7%	-	-14.1%
RARE Ultragenyx	Biotechnology Antibody,Biologic,Gene,Enzyme,Oligo	3.27B	37.2%	-	-55.5%	-	-42.8%
CNTA Centessa	Biotechnology Serpin, OXER1, Vasopressin	3.24B	32.9%	-	61.5%	-	35.9%
GRAL GRAIL	Biotechnology Diagnostic, Screening, Cancer	3.22B	40.2%	-	90.6%	-	464%
MLYS Mineralys	Biotechnology Hypertension, Mineralocorticoid	3.17B	32.9%	-	67.6%	-	152%
CGON CG Oncology	Biotechnology Cancer Immunotherapy Virus	3.16B	36.0%	-	6.01%	-	-1.44%
ZLAB Zai Lab	Biotechnology Zejula,Vyvgart,NUZYRA,Optune,Qinloc..	3.15B	31.0%	-	-12.1%	-	-30.3%
INDV Indivior Ordinary	Biotechnology Injection, Film, Tablet, Spray	3.14B	77.1%	2.63%	55.5%	31.0	164%
IRON Disc Medicine	Biotechnology Red, Blood, Iron, Drug, Clinical	3.13B	33.2%	-	27.9%	-	58.5%
BLTE Belite Bio	Biotechnology Eye Drug, Eye Gene Therapy, Vision	3.12B	37.1%	-	73.8%	-	36.6%
IMVT Immunovant	Biotechnology Antibody, Graves, Arthritis	3.05B	29.6%	-	10.0%	-	-30.7%
KNSA Kiniksa	Biotechnology Arcaxya, Mavripaxa, Sub):)	2.89B	59.6%	-	88.9%	779	36.6%
VCYT Veracyte	Biotechnology Cancer Biopsy Tests, Molecular	2.82B	57.6%	-	-2.45%	105	-14.9%
RXRX Recursion	Biotechnology Drug,Candidates,Pipeline	2.78B	31.8%	-	-63.1%	-	-28.7%
BEAM Beam Therapeutics	Biotechnology Base Editing Platform	2.75B	28.0%	-	-55.1%	-	-10.8%
SRRK Scholar Rock	Biotechnology Myostatin-Blocking Drug, Cancer	2.69B	27.0%	-	28.7%	-	-17.4%
NTLA Intellia	Biotechnology CRISPR, Gene, Editing	2.66B	34.3%	-	-57.5%	-	-27.9%
ALVO Alvotech	Biotechnology Biosimilar, Autoimmune, Eye, Bone	2.62B	54.1%	-	-19.5%	36.5	-48.3%
AGIO Agios Pharm	Biotechnology Pyruvate Kinase Activator, IDH	2.52B	43.1%	-	19.1%	3.84	-21.4%
CPRX Catalyst	Biotechnology Firdapse, Fycompa, Ruzurgi, Agamree	2.52B	91.9%	-	25.6%	12.5	-18.0%
ARQT Arcutis	Biotechnology Topical Cream, Seborrheic	2.50B	33.9%	-	34.1%	-	147%
TVTX Travere	Biotechnology Kidney Drug, Rare Disease Therapy	2.50B	26.5%	-	15.9%	-	40.8%
DYN Dyne Therapeutics	Biotechnology Muscle, Oligonucleotide, Therapy	2.44B	31.9%	-	7.76%	-	-32.0%
IDYA Ideaya Biosciences	Biotechnology Cancer Drugs, Oncology Therapies	2.43B	24.7%	-	39.9%	-	-9.59%
IBRX Immunitybio	Biotechnology Vaccine Cancer, Cell Therapy	2.39B	62.0%	-	-73.9%	-	-64.7%
DNLI Denali Therapeutics	Biotechnology Alzheimer, Parkinson, ALS	2.38B	26.3%	-	-75.2%	-	-48.6%
CDTX Cidara Therapeutics	Biotechnology Antifungal, Antiviral, Oncology	2.36B	16.5%	-	70.8%	-	616%
SRPT Sarepta	Biotechnology Gene Therapy, Antisense, Duchenne	2.36B	36.3%	-	-71.7%	-	-84.7%
FOLD Amicus Therapeutics	Biotechnology Enzyme,Replacement,Therapy,Gaucher,..	2.35B	48.1%	-	-40.4%	-	-35.2%
NNNN Anbio	Biotechnology Test, Kits, Devices, Reagents	2.32B	71.8%	-	87.5%	858	224%
COGT Cogent Biosciences	Biotechnology Kit, Bemarituzumab	2.29B	46.8%	-	33.0%	-	13.8%
GLPG Galapagos	Biotechnology Rheumatoid, Arthritis, Psoriatic	2.28B	41.0%	-	-12.6%	-	-7.60%
CELC Celcuity	Biotechnology Cancer Test, Therapy Candidate	2.20B	28.1%	-	67.9%	-	320%
MESO Mesoblast	Biotechnology Stem Cell Therapy, Regenerative	2.19B	31.9%	-	44.8%	-	57.2%
ETNB 89bio	Biotechnology Experimental Therapy, Liver	2.19B	29.8%	-	40.1%	-	56.6%
GLPG Galapagos	Biotechnology Filgotinib, Jyseleca, Crohns	2.13B	27.5%	-	-20.9%	-	-13.1%
VRDN Viridian	Biotechnology Antibody, Eye, Disease, Drug	1.98B	42.8%	-	9.20%	-	-10.0%
VERA Vera Therapeutics	Biotechnology Kidney, Antibody, Protein, Disease	1.95B	26.1%	3.50%	10.3%	-	-38.5%
TWST Twist Bioscience	Biotechnology Synthetic Dna,Gene,Silicon Chips	1.94B	38.2%	-	-45.9%	-	-39.2%
VCEL Vericel Ord	Biotechnology Cartilage Repair, Burn Wound, Cell	1.83B	59.4%	-	-17.8%	259	-36.1%
CLDX Celldex	Biotechnology Antibody, Vaccine, Cancer	1.78B	45.8%	-	-16.7%	-	-16.8%
RCUS Arcus Biosciences	Biotechnology Cancer, Immuno-Oncology	1.75B	36.9%	-	-25.9%	-	6.36%
STOK Stoke Therapeutics	Biotechnology STK-002,Zorevunersen,ASOs,TANGO,Gen..	1.74B	79.3%	-	44.8%	36.4	114%
BHVN Biohaven	Biotechnology Migraine Medicine, Neurology Drug	1.72B	41.2%	-	-24.0%	-	-71.0%
SYRE Spyre Therapeutics	Biotechnology Monoclonal, Antibodies	1.72B	31.0%	-	-42.0%	-	-40.1%
IMCR Immunocore Holdings	Biotechnology Cancer Therapy, ImmTac, Melanoma	1.69B	47.3%	-	-14.0%	-	-15.0%
MNKD MannKind	Biotechnology Inhaled,Insulin,Diabetes,Respirator..	1.68B	63.7%	-	7.97%	49.7	-33.4%
ABCL Abcellera Biologics	Biotechnology Antibody, Discovery, Therapeutics	1.67B	21.6%	-	-18.4%	-	62.5%
JANX Janux Therapeutics	Biotechnology T-Cell Redirectors, Prodrug Masks	1.61B	27.7%	-	-6.49%	-	-57.1%
EWTX Edgewise	Biotechnology Muscle, Disease, Drugs, Pipeline	1.59B	33.1%	-	-1.33%	-	-52.8%
GPCR Structure	Biotechnology Small,Molecule,Drug,Candidates,Obes..	1.58B	34.8%	-	0.96%	-	-28.3%
AUPH Aurinia	Biotechnology Kidney Transplant Drug	1.57B	89.1%	-	36.6%	27.7	38.8%
ATAI ATAI Life Sciences	Biotechnology Psychedelic, Intranasal, Oral	1.54B	40.7%	-	49.6%	-	335%
BCRX BioCryst	Biotechnology Oral Pill,Hereditary	1.54B	68.3%	-	-38.4%	-	-27.0%
PHVS Pharvaris BV	Biotechnology Bradykinin,Receptor,Antagonist,Drug..	1.48B	31.4%	-	49.1%	-	-24.4%
SANA Sana Biotechnology	Biotechnology Allogeneic Islet Therapy, CAR-T	1.43B	29.9%	-	6.46%	-	12.9%
DNTH Dianthus	Biotechnology Monoclonal Antibody, DNTH103	1.42B	28.9%	-	18.8%	-	1.72%
PGEN Precigen	Biotechnology UltraCAR-T, AdenoVerse, PRGN-3005	1.41B	31.7%	-	52.2%	-	314%
ZYME Zymeworks Common	Biotechnology Bispecific Antibodies	1.39B	33.5%	-	43.2%	-	16.2%
MEDCL Medincell	Biotechnology Schizophrenia, Postoperative Pain	1.38B	54.7%	-	71.0%	-	102%
IMNM Immunome	Biotechnology Antibody, Oncology, Bispecific	1.36B	47.3%	-	43.1%	-	10.4%
TSHA Taysha Gene	Biotechnology Gene, Therapy, AAV, CNS, Monogenic	1.35B	41.5%	-	48.7%	-	121%
NVAX Novavax	Biotechnology Vaccine, Covid, Nanoparticle	1.32B	38.2%	-	-49.5%	3.65	-27.8%
ORKA Oruka Therapeutics	Biotechnology Monoclonal Antibody	1.31B	32.0%	1.0%	20.4%	-	-18.0%
IMTX Immatics	Biotechnology TCR-Engineered Cell Therapy, TCR	1.24B	27.1%	-	-5.85%	-	-4.84%
TRML Tourmaline Bio	Biotechnology Monoclonal Antibody	1.23B	45.5%	1.0%	53.5%	-	52.7%
NBTX Nanobiotix	Biotechnology Nanoparticles, Radiotherapy	1.23B	46.4%	-	64.0%	-	256%
DVAX Dynavax	Biotechnology Vaccine, Infectious Diseases	1.22B	40.6%	-	-28.4%	-	-27.3%
ARDX Ardelyx	Biotechnology Kidney Drug, Bowel Drug	1.21B	28.6%	-	35.7%	-	-28.3%
CVAC CureVac	Biotechnology mRNA Vaccines, mRNA Therapies	1.21B	85.0%	-	3.78%	5.36	61.4%
ORIC Oric	Biotechnology Androgen, Kinase, Precision	1.21B	33.8%	-	57.5%	-	19.4%
OPK Opko Health	Biotechnology Diagnostics, Pharmaceuticals	1.19B	19.3%	-	-42.6%	-	-19.0%
ZBIO Zenas BioPharma	Biotechnology Bifunctional Monoclonal Antibody	1.18B	33.4%	-	64.0%	-	19.9%
NUVB Nuvation Bio	Biotechnology Oncology Pipeline Drug Candidates	1.17B	37.1%	-	37.0%	-	85.5%
SNDX Syndax	Biotechnology Antibody, Kinase, Inhibitor	1.14B	51.1%	-	-39.6%	-	-40.4%
UPB Upstream Bio	Biotechnology Verekitug, Asthma, Rhinosinusitis	1.13B	39.4%	-	33.0%	-	-12.8%
OCS Oculis Holding	Biotechnology Ophthalmology,Eye,Drugs,Therapy,Tre..	1.13B	23.9%	-	59.2%	-	-1.37%
RLAY Relay Therapeutics	Biotechnology PI3Ka Inhibitor, Estrogen	1.12B	34.6%	-	-41.9%	-	8.35%
XNCR Xencor	Biotechnology Engineered Monoclonal Antibodies	1.05B	19.5%	-	-75.8%	-	-43.3%
TNGX Tango Therapeutics	Biotechnology PRMT5 Inhibitor, Glioblastoma	1.02B	30.8%	-	18.5%	-	17.7%
MDXG MiMedx	Biotechnology Allograft, Wound, Graft, Membrane	1.00B	75.1%	-	27.8%	32.2	9.62%
NANO Nanobiotix S.A	Biotechnology Nanoparticle, Radiotherapy	993M	41.6%	-	59.8%	-	248%
MNMD Mind Medicine	Biotechnology MM120, MM402, Anxiety, ADHD, Autism	979M	26.7%	-	56.7%	-	78.0%
PRME Prime Medicine	Biotechnology Gene Editing, Prime Editing	972M	41.0%	-	-37.7%	-	-9.91%
ANAB AnaptysBio	Biotechnology Antibody, Autoimmune	969M	42.6%	-	30.5%	-	38.6%
LENZ LENZ Therapeutics	Biotechnology Presbyopia, Accommodative	968M	38.6%	1.0%	30.5%	-	-7.11%
KOD Kodiak Sciences	Biotechnology Anti-VEGF, Biopolymer Conjugate	953M	35.8%	-	36.5%	-	349%
BCAX Bicara	Biotechnology Ficerafusp Alfa, Bifunctional	936M	27.9%	-	-45.9%	-	-41.5%
PROK ProKidney	Biotechnology Cell Therapy, Regenerative Medicine	933M	53.5%	-	-24.1%	-	54.5%
PHARM Pharming	Biotechnology RUCONEST, Joenja, OTL-105	929M	61.3%	-	28.1%	-	19.9%
IVA Inventiva	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	904M	46.0%	-	18.5%	-	26.7%
SPRY ARS	Biotechnology Cancer Antibody,Immune	900M	28.6%	-	8.07%	-	-49.1%
RZLT Rezolute	Biotechnology Antibody, Hyperinsulinism	893M	32.4%	-	58.2%	-	52.2%
KURA Kura Oncology	Biotechnology Menin Inhibitor, Farnesyl	891M	49.6%	-	-48.3%	-	-48.1%
ABUS Arbutus Biopharma	Biotechnology RNAi Therapeutic, PD-L1 Inhibitor	845M	31.1%	-	46.8%	-	3.55%
GHRS GH Research	Biotechnology Mebufotenin, Depression	837M	29.4%	-	30.8%	-	26.9%
VIR Vir Biotechnology	Biotechnology HDV, RSV, HPV, Coronavirus, TCE	831M	33.0%	-	-80.4%	-	-34.2%
VLA Valneva SE	Biotechnology Japanese Encephalitis, Cholera	823M	18.1%	-	-9.52%	-	26.2%
PVLA Palvella	Biotechnology Topical Rapamycin Gel, Microcystic	809M	25.7%	-	19.8%	-	292%
NRIX Nurix Therapeutics	Biotechnology BTK Degrader, IRAK4 Degrader	801M	30.8%	-	-44.4%	-	-55.3%
IOVA Iovance	Biotechnology Amtagvi, Proleukin, Lifileucel	789M	42.5%	-	-86.2%	-	-85.1%
DNA Ginkgo Bioworks	Biotechnology Cell Engineering, Biosecurity	784M	18.4%	-	-32.5%	-	29.1%
URGN UroGen Pharma	Biotechnology Jelmyto, UGN-102, UGN-103	784M	34.6%	-	51.4%	-	28.5%
AKBA Akebia Ther	Biotechnology Anemia,Hyperphosphatemia,Iron-Defic..	777M	43.6%	-	69.4%	-	4.12%
SION Sionna	Biotechnology CFTR,Cystic,COPD,Lungs,Genes	769M	34.9%	-	87.0%	-	86.7%
GERN Geron	Biotechnology telomerase, inhibitor, oncology	766M	36.3%	-	-52.6%	-	-74.8%
DAWN Day One	Biotechnology Tovorafenib, DAY301, VRK1 Inhibitor	765M	33.0%	-	-78.4%	-	-59.0%
CDNA CareDx	Biotechnology Kidney, Heart, Transplant	760M	50.2%	-	-58.6%	13.6	-46.9%
TYRA Tyra Biosciences	Biotechnology Precision Medicine Platform, FGFR	758M	32.1%	-	21.7%	-	-17.2%
GYRE Gyre Therapeutics	Biotechnology Idiopathic Pulmonary Fibrosis	754M	53.9%	1.0%	-13.2%	415	-56.2%
SVRA Savara	Biotechnology Molgramostim, Proteinosis	754M	26.5%	-	58.7%	-	-0.43%
MYGN Myriad Genetics	Biotechnology Hereditary Cancer, Companion	752M	38.1%	0.08%	-76.0%	-	-70.6%
AVXL Anavex Life	Biotechnology Cns,Alzheimer,Parkinson,Rett,Epilep..	751M	30.8%	-	-11.3%	-	18.5%
AVBP ArriVent	Biotechnology Firmonertinib, ARR-217, ARR-002	750M	42.6%	-	-29.6%	-	-50.5%
CMPX Compass	Biotechnology Tovecimig, CTX-471, CTX-8371	731M	31.7%	-	21.0%	-	83.4%
MGTX MeiraGTx Holdings	Biotechnology Gene Therapies, Retinal Diseases	702M	27.2%	-	25.0%	-	25.2%
ATXS Astria Therapeutics	Biotechnology Monoclonal, Antibody, Plasma	699M	32.0%	-	0.94%	-	-12.6%
CSTL Castle Biosciences	Biotechnology Melanoma, Squamous, Uveal	689M	58.5%	-	-37.4%	-	-40.9%
IMAB I-Mab	Biotechnology Cancer Treatments, Antibodies	665M	29.1%	-	21.3%	-	241%
ZVRA Zevra Therapeutics	Biotechnology KP1077, Celiprolol, AZSTARYS	661M	29.7%	-	48.2%	-	1.39%
ERAS Erasca	Biotechnology Naporafenib, ERAS-0015, ERAS-4001	644M	34.7%	-	-60.0%	-	-23.2%
ABSI Absci	Biotechnology AI,Antibody,Therapeutics,Preclinica..	639M	29.7%	-	-0.51%	-	-16.7%
GLUE Monte Rosa	Biotechnology MRT-2359, MRT-6160, MRT-8102, CDK2	621M	67.1%	-	7.34%	25.8	18.9%
ESPR Esperion	Biotechnology Cholesterol-Lowering Tablets	614M	52.7%	-	-37.4%	-	12.4%
KALV Kalvista	Biotechnology Plasma Kallikrein Inhibitors, Oral	603M	47.2%	-	42.1%	-	-17.4%
MLTX MoonLake	Biotechnology Sonelokimab, Tri-Specific	596M	29.0%	-	14.2%	-	-82.4%
RGNX Regenxbio	Biotechnology Gene,Therapy,AAV,Platform,Pipeline	593M	23.3%	-	-21.4%	-	22.2%
MBX MBX Biosciences	Biotechnology Hypoparathyroidism, Hypoglycemia	591M	36.1%	-	19.8%	-	-17.5%
CRVS Corvus	Biotechnology Kinase Inhibitor, Adenosine	572M	33.2%	-	41.7%	-	-25.7%
VSTM Verastem	Biotechnology Avutometinib, Defactinib	567M	40.8%	-	42.0%	-	108%
BCYC Bicycle	Biotechnology Bicycle, Conjugate, Nectin-4	563M	38.9%	-	-81.0%	-	-69.3%
OLMA Olema	Biotechnology Palazestrant, OP-3136, KAT6	562M	33.4%	-	15.4%	-	-36.4%
GOSS Gossamer Bio	Biotechnology Seralutinib, GB002, PAH Therapy	529M	34.2%	-	-9.70%	-	128%
PRTA Prothena	Biotechnology Neurodegeneration, Antibody	529M	58.7%	-	-75.0%	-	-51.1%

ABBV
AbbVie

Biotechnology
Biologics, Immunology, Oncology

403B

55.6%

70.4%

85.4%

109

-1.20%

AMGN
Amgen

Biotechnology
Rheumatoid Arthritis, Psoriasis

159B

80.8%

68.8%

34.4%

23.9

-19.4%

GILD
Gilead Sciences

Biotechnology
Antivirals, Oncology, Hepatitis

150B

78.6%

61.7%

87.5%

24.0

16.4%

VRTX
Vertex

Biotechnology
Cystic Fibrosis, Sickle Cell, Beta

108B

86.4%

-

19.7%

30.0

-25.5%

REGN
Regeneron

Biotechnology
Eylea, Dupixent, Libtayo

62.0B

79.3%

13.5%

-28.9%

14.5

-40.0%

ALNY
Alnylam

Biotechnology
RNAi Therapeutics, Patisiran

60.7B

33.2%

-

84.3%

-

34.6%

ARGX
argenx

Biotechnology
Antibody,Autoimmune,Therapy,FcRn,Ig..

50.4B

68.8%

-

76.0%

41.7

25.3%

HLN
Haleon

Biotechnology
Toothpaste, Vitamins, Pain-Relief

41.8B

52.7%

53.5%

49.2%

20.6

-19.6%

ONC
BeiGene

Biotechnology
BTK-Inhibitor, Anti-PD-1

35.8B

56.1%

-

57.1%

-

26.1%

INSM
Insmed

Biotechnology
Inhaled Antibiotic, DPP1

35.3B

38.0%

-

81.8%

-

133%

22UA
BioNTech SE

Biotechnology
Cancer Vaccines, mRNA Therapies

25.6B

12.8%

1.0%

-57.9%

-

-26.8%

NTRA
Natera

Biotechnology
Prenatal Screening, Carrier

24.9B

47.6%

-

64.9%

-

28.5%

BNTX
BioNTech SE

Biotechnology
Oncology Vaccines,Checkpoint

24.9B

13.8%

1.0%

-43.3%

-

-22.6%

BIIB
Biogen

Biotechnology
Multiple Sclerosis Therapies

22.0B

65.5%

-

-61.1%

14.3

-30.4%

GMAB
Genmab AS

Biotechnology
Antibody, Cancer, Lymphoma

20.4B

85.8%

-

-7.24%

17.2

7.07%

UTHR
United Therapeutics

Biotechnology
Treprostinil, Treprostinil

18.9B

85.7%

-

57.9%

16.3

5.78%

INCY
Incyte

Biotechnology
JAKAFI, MONJUVI, PEMAZYRE

18.2B

87.5%

-

18.6%

21.6

5.57%

BIM
Biomerieux

Biotechnology
Diagnostic, Instruments, Reagents

15.6B

80.3%

61.1%

35.7%

35.7

-11.8%

SMMT
Summit Therapeutics

Biotechnology
Antibody, Immunotherapy, Oncology

14.5B

45.6%

-

61.5%

-

-15.8%

NBIX
Neurocrine

Biotechnology
Movement, Endocrine

14.3B

81.1%

-

34.5%

42.6

-6.41%

ERF
Eurofins

Biotechnology
Testing, Laboratory, Services

13.0B

68.2%

2.66%

15.8%

27.7

15.1%

ASND
Ascendis Pharma AS

Biotechnology
Growth Hormone

12.2B

32.9%

-

72.2%

-

39.8%

EXAS
EXACT Sciences

Biotechnology
Colon, Breast, Biomarker, Tumor

12.0B

45.3%

-

12.4%

-

-24.4%

ROIV
Roivant Sciences

Biotechnology
Antibody, Inhibitor, Activator

11.8B

29.8%

-

73.9%

-

40.1%

IONS
Ionis

Biotechnology
Triglyceride,Neuromuscular,ADS,ATTR..

11.3B

26.4%

0.21%

55.7%

-

59.2%

EXEL
Exelixis

Biotechnology
Cabozantinib, Cobimetinib

10.8B

94.3%

-

79.4%

18.6

1.18%

BMRN
Biomarin

Biotechnology
Enzyme replacement therapy

10.5B

83.7%

-

-62.6%

16.1

-34.4%

BBIO
BridgeBio Pharma

Biotechnology
Attruby, Infigratinib, Encaleret

10.4B

46.6%

-

78.1%

-

125%

RVMD
Revolution

Biotechnology
Targeted Therapies, RAS

10.1B

29.2%

-

43.2%

-

-1.74%

MRNA
Moderna

Biotechnology
Respiratory Vaccines, Latent

9.90B

25.0%

-

-84.4%

-

-56.7%

MDGL
Madrigal

Biotechnology
Rezdiffra, MASH, Thyroid, Agonist

9.57B

49.0%

-

77.5%

-

66.9%

GRFS
Grifols

Biotechnology
Immunoglobulin, Albumin, Clotting

8.00B

65.3%

41.6%

27.3%

18.6

-10.5%

RGC
Regencell

Biotechnology
TCM,Neurocognitive,ADHD,Autism,Herb..

7.92B

36.4%

-

74.5%

-

7,481%

HALO
Halozyme

Biotechnology
Hyaluronidase Enzyme, Hylenex

7.74B

86.3%

-

53.9%

15.1

7.68%

CYTK
Cytokinetics

Biotechnology
Omecamtiv, Aficamten, CK089, CK586

7.42B

32.1%

-

36.5%

-

2.26%

RYTM
Rhythm

Biotechnology
IMCIVREE, Obesity-Drug

7.34B

49.2%

-

90.0%

-

90.2%

ABVX
Abivax American

Biotechnology
Hepatitis,HIV,Autoimmune,Infection

7.21B

38.5%

-

65.3%

-

738%

MRUS
Merus BV

Biotechnology
Bispecific,Antibodies,Cancer,Clinic..

7.19B

33.4%

-

87.1%

-

56.3%

ABVX
Abivax

Biotechnology
Drug, Phase3, Ulcerative, Crohns

7.16B

38.7%

-

54.7%

-

682%

RNA
Avidity Biosciences

Biotechnology
Antibody, Oligonucleotide

6.99B

32.2%

-

66.2%

-

35.9%

NUVL
Nuvalent

Biotechnology
ROS1 Inhibitor, ALK Inhibitor

6.67B

28.7%

-

60.6%

-

-8.30%

LEGN
Legend Biotech

Biotechnology
CAR-T, BCMA, Gamma-Delta

6.07B

32.2%

-

-38.7%

-

-38.6%

CRSP
Crispr Therapeutics

Biotechnology
Beta Thalassemia Therapy, Sickle

5.69B

25.8%

-

15.5%

-

7.45%

PCVX
Vaxcyte

Biotechnology
Pneumonia Vaccine, Strep Vaccine

5.50B

30.7%

-

-16.9%

-

-64.5%

TGTX
TG Therapeutics

Biotechnology
Briumvi, Ublituximab, TG-1701

5.36B

66.7%

-

55.5%

88.9

14.1%

KRYS
Krystal Biotech

Biotechnology
VYJUVEK, Gene Therapies

5.36B

82.6%

-

51.0%

37.6

-9.20%

PTCT
PTC Therapeutics

Biotechnology
Translarna, Emflaza, Upstaza

5.31B

79.9%

-

56.4%

9.47

41.2%

ARWR
Arrowhead

Biotechnology
Arrowhead, siRNA, Therapy, Liver

5.09B

34.9%

-

1.68%

-

80.9%

ALKS
Alkermes

Biotechnology
Schizophrenia, Bipolar, Alcohol

4.96B

87.1%

-

30.4%

14.5

-1.26%

PRAX
Praxis Precision

Biotechnology
Cns Therapies, Epilepsy Treatments

4.87B

33.4%

-

31.3%

-

142%

ACLX
Arcellx

Biotechnology
Anitocabtagene, ACLX-001

4.82B

37.4%

-

58.8%

-

-15.0%

PTGX
Protagonist

Biotechnology
Inject, Hepcidin, Mimetic

4.66B

52.1%

-

83.8%

103

37.8%

KYMR
Kymera Therapeutics

Biotechnology
IRAK4 Program,STAT6 Program,TYK2

4.43B

29.4%

-

42.6%

-

8.64%

AKRO
Akero Therapeutics

Biotechnology
Efruxifermin, EFX, MASH Treatment

4.32B

30.8%

-

49.4%

-

49.0%

MTSR
Metsera, Common

Biotechnology
Injectable, Oral, Peptides

4.12B

47.9%

-

88.4%

-

212%

NAMS
NewAmsterdam

Biotechnology
Cholesterol, Lowering, Medicine

4.02B

37.2%

-

75.1%

-

81.3%

CRNX
Crinetics

Biotechnology
Paltusotine, Atumelnant, CRN09682

3.91B

28.9%

-

28.7%

-

-34.6%

VKTX
Viking Therapeutics

Biotechnology
Drugs, Liver, Diabetes, Obesity

3.83B

28.9%

-

31.8%

-

-55.2%

APLS
Apellis

Biotechnology
Empaveli, Syfovre, Geographical

3.76B

39.3%

-

-63.9%

-

-36.9%

QURE
Uniqure

Biotechnology
Gene Therapy, Hemophilia Treatment

3.76B

42.2%

-

44.6%

-

807%

ACAD
ACADIA

Biotechnology
Pimavanserin, Trofinetide

3.67B

66.1%

-

46.4%

16.3

29.8%

APGE
Apogee

Biotechnology
Cystic Fibrosis,’Atopic

3.62B

48.5%

-

41.6%

-

-14.0%

LGND
Ligand

Biotechnology
Antiviral,Oncology,Vaccine,Respirat..

3.54B

36.4%

0.14%

76.0%

-

43.6%

MIRM
Mirum

Biotechnology
LIVMARLI, Cholbam, Chenodal

3.52B

43.1%

-

91.3%

-

55.3%

SLNO
Soleno Therapeutics

Biotechnology
Diazoxide, Choline, Prader-Willi

3.48B

51.6%

-

77.0%

-

4.80%

ADMA
ADMA Biologics

Biotechnology
Immune Globulin, Hepatitis B

3.43B

85.0%

-

42.7%

16.9

-24.1%

XENE
Xenon

Biotechnology
Seizure Drugs, Pain Drugs

3.32B

37.1%

-

12.7%

-

-14.1%

RARE
Ultragenyx

Biotechnology
Antibody,Biologic,Gene,Enzyme,Oligo

3.27B

37.2%

-

-55.5%

-

-42.8%

CNTA
Centessa

Biotechnology
Serpin, OXER1, Vasopressin

3.24B

32.9%

-

61.5%

-

35.9%

GRAL
GRAIL

Biotechnology
Diagnostic, Screening, Cancer

3.22B

40.2%

-

90.6%

-

464%

MLYS
Mineralys

Biotechnology
Hypertension, Mineralocorticoid

3.17B

32.9%

-

67.6%

-

152%

CGON
CG Oncology

Biotechnology
Cancer Immunotherapy Virus

3.16B

36.0%

-

6.01%

-

-1.44%

ZLAB
Zai Lab

Biotechnology
Zejula,Vyvgart,NUZYRA,Optune,Qinloc..

3.15B

31.0%

-

-12.1%

-

-30.3%

INDV
Indivior Ordinary

Biotechnology
Injection, Film, Tablet, Spray

3.14B

77.1%

2.63%

55.5%

31.0

164%

IRON
Disc Medicine

Biotechnology
Red, Blood, Iron, Drug, Clinical

3.13B

33.2%

-

27.9%

-

58.5%

BLTE
Belite Bio

Biotechnology
Eye Drug, Eye Gene Therapy, Vision

3.12B

37.1%

-

73.8%

-

36.6%

IMVT
Immunovant

Biotechnology
Antibody, Graves, Arthritis

3.05B

29.6%

-

10.0%

-

-30.7%

KNSA
Kiniksa

Biotechnology
Arcaxya, Mavripaxa, Sub):)

2.89B

59.6%

-

88.9%

779

36.6%

VCYT
Veracyte

Biotechnology
Cancer Biopsy Tests, Molecular

2.82B

57.6%

-

-2.45%

105

-14.9%

RXRX
Recursion

Biotechnology
Drug,Candidates,Pipeline

2.78B

31.8%

-

-63.1%

-

-28.7%

BEAM
Beam Therapeutics

Biotechnology
Base Editing Platform

2.75B

28.0%

-

-55.1%

-

-10.8%

SRRK
Scholar Rock

Biotechnology
Myostatin-Blocking Drug, Cancer

2.69B

27.0%

-

28.7%

-

-17.4%

NTLA
Intellia

Biotechnology
CRISPR, Gene, Editing

2.66B

34.3%

-

-57.5%

-

-27.9%

ALVO
Alvotech

Biotechnology
Biosimilar, Autoimmune, Eye, Bone

2.62B

54.1%

-

-19.5%

36.5

-48.3%

AGIO
Agios Pharm

Biotechnology
Pyruvate Kinase Activator, IDH

2.52B

43.1%

-

19.1%

3.84

-21.4%

CPRX
Catalyst

Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree

2.52B

91.9%

-

25.6%

12.5

-18.0%

ARQT
Arcutis

Biotechnology
Topical Cream, Seborrheic

2.50B

33.9%

-

34.1%

-

147%

TVTX
Travere

Biotechnology
Kidney Drug, Rare Disease Therapy

2.50B

26.5%

-

15.9%

-

40.8%

DYN
Dyne Therapeutics

Biotechnology
Muscle, Oligonucleotide, Therapy

2.44B

31.9%

-

7.76%

-

-32.0%

IDYA
Ideaya Biosciences

Biotechnology
Cancer Drugs, Oncology Therapies

2.43B

24.7%

-

39.9%

-

-9.59%

IBRX
Immunitybio

Biotechnology
Vaccine Cancer, Cell Therapy

2.39B

62.0%

-

-73.9%

-

-64.7%

DNLI
Denali Therapeutics

Biotechnology
Alzheimer, Parkinson, ALS

2.38B

26.3%

-

-75.2%

-

-48.6%

CDTX
Cidara Therapeutics

Biotechnology
Antifungal, Antiviral, Oncology

2.36B

16.5%

-

70.8%

-

616%

SRPT
Sarepta

Biotechnology
Gene Therapy, Antisense, Duchenne

2.36B

36.3%

-

-71.7%

-

-84.7%

FOLD
Amicus Therapeutics

Biotechnology
Enzyme,Replacement,Therapy,Gaucher,..

2.35B

48.1%

-

-40.4%

-

-35.2%

NNNN
Anbio

Biotechnology
Test, Kits, Devices, Reagents

2.32B

71.8%

-

87.5%

858

224%

COGT
Cogent Biosciences

Biotechnology
Kit, Bemarituzumab

2.29B

46.8%

-

33.0%

-

13.8%

GLPG
Galapagos

Biotechnology
Rheumatoid, Arthritis, Psoriatic

2.28B

41.0%

-

-12.6%

-

-7.60%

CELC
Celcuity

Biotechnology
Cancer Test, Therapy Candidate

2.20B

28.1%

-

67.9%

-

320%

MESO
Mesoblast

Biotechnology
Stem Cell Therapy, Regenerative

2.19B

31.9%

-

44.8%

-

57.2%

ETNB
89bio

Biotechnology
Experimental Therapy, Liver

2.19B

29.8%

-

40.1%

-

56.6%

GLPG
Galapagos

Biotechnology
Filgotinib, Jyseleca, Crohns

2.13B

27.5%

-

-20.9%

-

-13.1%

VRDN
Viridian

Biotechnology
Antibody, Eye, Disease, Drug

1.98B

42.8%

-

9.20%

-

-10.0%

VERA
Vera Therapeutics

Biotechnology
Kidney, Antibody, Protein, Disease

1.95B

26.1%

3.50%

10.3%

-

-38.5%

TWST
Twist Bioscience

Biotechnology
Synthetic Dna,Gene,Silicon Chips

1.94B

38.2%

-

-45.9%

-

-39.2%

VCEL
Vericel Ord

Biotechnology
Cartilage Repair, Burn Wound, Cell

1.83B

59.4%

-

-17.8%

259

-36.1%

CLDX
Celldex

Biotechnology
Antibody, Vaccine, Cancer

1.78B

45.8%

-

-16.7%

-

-16.8%

RCUS
Arcus Biosciences

Biotechnology
Cancer, Immuno-Oncology

1.75B

36.9%

-

-25.9%

-

6.36%

STOK
Stoke Therapeutics

Biotechnology
STK-002,Zorevunersen,ASOs,TANGO,Gen..

1.74B

79.3%

-

44.8%

36.4

114%

BHVN
Biohaven

Biotechnology
Migraine Medicine, Neurology Drug

1.72B

41.2%

-

-24.0%

-

-71.0%

SYRE
Spyre Therapeutics

Biotechnology
Monoclonal, Antibodies

1.72B

31.0%

-

-42.0%

-

-40.1%

IMCR
Immunocore Holdings

Biotechnology
Cancer Therapy, ImmTac, Melanoma

1.69B

47.3%

-

-14.0%

-

-15.0%

MNKD
MannKind

Biotechnology
Inhaled,Insulin,Diabetes,Respirator..

1.68B

63.7%

-

7.97%

49.7

-33.4%

ABCL
Abcellera Biologics

Biotechnology
Antibody, Discovery, Therapeutics

1.67B

21.6%

-

-18.4%

-

62.5%

JANX
Janux Therapeutics

Biotechnology
T-Cell Redirectors, Prodrug Masks

1.61B

27.7%

-

-6.49%

-

-57.1%

EWTX
Edgewise

Biotechnology
Muscle, Disease, Drugs, Pipeline

1.59B

33.1%

-

-1.33%

-

-52.8%

GPCR
Structure

Biotechnology
Small,Molecule,Drug,Candidates,Obes..

1.58B

34.8%

-

0.96%

-

-28.3%

AUPH
Aurinia

Biotechnology
Kidney Transplant Drug

1.57B

89.1%

-

36.6%

27.7

38.8%

ATAI
ATAI Life Sciences

Biotechnology
Psychedelic, Intranasal, Oral

1.54B

40.7%

-

49.6%

-

335%

BCRX
BioCryst

Biotechnology
Oral Pill,Hereditary

1.54B

68.3%

-

-38.4%

-

-27.0%

PHVS
Pharvaris BV

Biotechnology
Bradykinin,Receptor,Antagonist,Drug..

1.48B

31.4%

-

49.1%

-

-24.4%

SANA
Sana Biotechnology

Biotechnology
Allogeneic Islet Therapy, CAR-T

1.43B

29.9%

-

6.46%

-

12.9%

DNTH
Dianthus

Biotechnology
Monoclonal Antibody, DNTH103

1.42B

28.9%

-

18.8%

-

1.72%

PGEN
Precigen

Biotechnology
UltraCAR-T, AdenoVerse, PRGN-3005

1.41B

31.7%

-

52.2%

-

314%

ZYME
Zymeworks Common

Biotechnology
Bispecific Antibodies

1.39B

33.5%

-

43.2%

-

16.2%

MEDCL
Medincell

Biotechnology
Schizophrenia, Postoperative Pain

1.38B

54.7%

-

71.0%

-

102%

IMNM
Immunome

Biotechnology
Antibody, Oncology, Bispecific

1.36B

47.3%

-

43.1%

-

10.4%

TSHA
Taysha Gene

Biotechnology
Gene, Therapy, AAV, CNS, Monogenic

1.35B

41.5%

-

48.7%

-

121%

NVAX
Novavax

Biotechnology
Vaccine, Covid, Nanoparticle

1.32B

38.2%

-

-49.5%

3.65

-27.8%

ORKA
Oruka Therapeutics

Biotechnology
Monoclonal Antibody

1.31B

32.0%

1.0%

20.4%

-

-18.0%

IMTX
Immatics

Biotechnology
TCR-Engineered Cell Therapy, TCR

1.24B

27.1%

-

-5.85%

-

-4.84%

TRML
Tourmaline Bio

Biotechnology
Monoclonal Antibody

1.23B

45.5%

1.0%

53.5%

-

52.7%

NBTX
Nanobiotix

Biotechnology
Nanoparticles, Radiotherapy

1.23B

46.4%

-

64.0%

-

256%

DVAX
Dynavax

Biotechnology
Vaccine, Infectious Diseases

1.22B

40.6%

-

-28.4%

-

-27.3%

ARDX
Ardelyx

Biotechnology
Kidney Drug, Bowel Drug

1.21B

28.6%

-

35.7%

-

-28.3%

CVAC
CureVac

Biotechnology
mRNA Vaccines, mRNA Therapies

1.21B

85.0%

-

3.78%

5.36

61.4%

ORIC
Oric

Biotechnology
Androgen, Kinase, Precision

1.21B

33.8%

-

57.5%

-

19.4%

OPK
Opko Health

Biotechnology
Diagnostics, Pharmaceuticals

1.19B

19.3%

-

-42.6%

-

-19.0%

ZBIO
Zenas BioPharma

Biotechnology
Bifunctional Monoclonal Antibody

1.18B

33.4%

-

64.0%

-

19.9%

NUVB
Nuvation Bio

Biotechnology
Oncology Pipeline Drug Candidates

1.17B

37.1%

-

37.0%

-

85.5%

SNDX
Syndax

Biotechnology
Antibody, Kinase, Inhibitor

1.14B

51.1%

-

-39.6%

-

-40.4%

UPB
Upstream Bio

Biotechnology
Verekitug, Asthma, Rhinosinusitis

1.13B

39.4%

-

33.0%

-

-12.8%

OCS
Oculis Holding

Biotechnology
Ophthalmology,Eye,Drugs,Therapy,Tre..

1.13B

23.9%

-

59.2%

-

-1.37%

RLAY
Relay Therapeutics

Biotechnology
PI3Ka Inhibitor, Estrogen

1.12B

34.6%

-

-41.9%

-

8.35%

XNCR
Xencor

Biotechnology
Engineered Monoclonal Antibodies

1.05B

19.5%

-

-75.8%

-

-43.3%

TNGX
Tango Therapeutics

Biotechnology
PRMT5 Inhibitor, Glioblastoma

1.02B

30.8%

-

18.5%

-

17.7%

MDXG
MiMedx

Biotechnology
Allograft, Wound, Graft, Membrane

1.00B

75.1%

-

27.8%

32.2

9.62%

NANO
Nanobiotix S.A

Biotechnology
Nanoparticle, Radiotherapy

993M

41.6%

-

59.8%

-

248%

MNMD
Mind Medicine

Biotechnology
MM120, MM402, Anxiety, ADHD, Autism

979M

26.7%

-

56.7%

-

78.0%

PRME
Prime Medicine

Biotechnology
Gene Editing, Prime Editing

972M

41.0%

-

-37.7%

-

-9.91%

ANAB
AnaptysBio

Biotechnology
Antibody, Autoimmune

969M

42.6%

-

30.5%

-

38.6%

LENZ
LENZ Therapeutics

Biotechnology
Presbyopia, Accommodative

968M

38.6%

1.0%

30.5%

-

-7.11%

KOD
Kodiak Sciences

Biotechnology
Anti-VEGF, Biopolymer Conjugate

953M

35.8%

-

36.5%

-

349%

BCAX
Bicara

Biotechnology
Ficerafusp Alfa, Bifunctional

936M

27.9%

-

-45.9%

-

-41.5%

PROK
ProKidney

Biotechnology
Cell Therapy, Regenerative Medicine

933M

53.5%

-

-24.1%

-

54.5%

PHARM
Pharming

Biotechnology
RUCONEST, Joenja, OTL-105

929M

61.3%

-

28.1%

-

19.9%

IVA
Inventiva

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

904M

46.0%

-

18.5%

-

26.7%

SPRY
ARS

Biotechnology
Cancer Antibody,Immune

900M

28.6%

-

8.07%

-

-49.1%

RZLT
Rezolute

Biotechnology
Antibody, Hyperinsulinism

893M

32.4%

-

58.2%

-

52.2%

KURA
Kura Oncology

Biotechnology
Menin Inhibitor, Farnesyl

891M

49.6%

-

-48.3%

-

-48.1%

ABUS
Arbutus Biopharma

Biotechnology
RNAi Therapeutic, PD-L1 Inhibitor

845M

31.1%

-

46.8%

-

3.55%

GHRS
GH Research

Biotechnology
Mebufotenin, Depression

837M

29.4%

-

30.8%

-

26.9%

VIR
Vir Biotechnology

Biotechnology
HDV, RSV, HPV, Coronavirus, TCE

831M

33.0%

-

-80.4%

-

-34.2%

VLA
Valneva SE

Biotechnology
Japanese Encephalitis, Cholera

823M

18.1%

-

-9.52%

-

26.2%

PVLA
Palvella

Biotechnology
Topical Rapamycin Gel, Microcystic

809M

25.7%

-

19.8%

-

292%

NRIX
Nurix Therapeutics

Biotechnology
BTK Degrader, IRAK4 Degrader

801M

30.8%

-

-44.4%

-

-55.3%

IOVA
Iovance

Biotechnology
Amtagvi, Proleukin, Lifileucel

789M

42.5%

-

-86.2%

-

-85.1%

DNA
Ginkgo Bioworks

Biotechnology
Cell Engineering, Biosecurity

784M

18.4%

-

-32.5%

-

29.1%

URGN
UroGen Pharma

Biotechnology
Jelmyto, UGN-102, UGN-103

784M

34.6%

-

51.4%

-

28.5%

AKBA
Akebia Ther

Biotechnology
Anemia,Hyperphosphatemia,Iron-Defic..

777M

43.6%

-

69.4%

-

4.12%

SION
Sionna

Biotechnology
CFTR,Cystic,COPD,Lungs,Genes

769M

34.9%

-

87.0%

-

86.7%

GERN
Geron

Biotechnology
telomerase, inhibitor, oncology

766M

36.3%

-

-52.6%

-

-74.8%

DAWN
Day One

Biotechnology
Tovorafenib, DAY301, VRK1 Inhibitor

765M

33.0%

-

-78.4%

-

-59.0%

CDNA
CareDx

Biotechnology
Kidney, Heart, Transplant

760M

50.2%

-

-58.6%

13.6

-46.9%

TYRA
Tyra Biosciences

Biotechnology
Precision Medicine Platform, FGFR

758M

32.1%

-

21.7%

-

-17.2%

GYRE
Gyre Therapeutics

Biotechnology
Idiopathic Pulmonary Fibrosis

754M

53.9%

1.0%

-13.2%

415

-56.2%

SVRA
Savara

Biotechnology
Molgramostim, Proteinosis

754M

26.5%

-

58.7%

-

-0.43%

MYGN
Myriad Genetics

Biotechnology
Hereditary Cancer, Companion

752M

38.1%

0.08%

-76.0%

-

-70.6%

AVXL
Anavex Life

Biotechnology
Cns,Alzheimer,Parkinson,Rett,Epilep..

751M

30.8%

-

-11.3%

-

18.5%

AVBP
ArriVent

Biotechnology
Firmonertinib, ARR-217, ARR-002

750M

42.6%

-

-29.6%

-

-50.5%

CMPX
Compass

Biotechnology
Tovecimig, CTX-471, CTX-8371

731M

31.7%

-

21.0%

-

83.4%

MGTX
MeiraGTx Holdings

Biotechnology
Gene Therapies, Retinal Diseases

702M

27.2%

-

25.0%

-

25.2%

ATXS
Astria Therapeutics

Biotechnology
Monoclonal, Antibody, Plasma

699M

32.0%

-

0.94%

-

-12.6%

CSTL
Castle Biosciences

Biotechnology
Melanoma, Squamous, Uveal

689M

58.5%

-

-37.4%

-

-40.9%

IMAB
I-Mab

Biotechnology
Cancer Treatments, Antibodies

665M

29.1%

-

21.3%

-

241%

ZVRA
Zevra Therapeutics

Biotechnology
KP1077, Celiprolol, AZSTARYS

661M

29.7%

-

48.2%

-

1.39%

ERAS
Erasca

Biotechnology
Naporafenib, ERAS-0015, ERAS-4001

644M

34.7%

-

-60.0%

-

-23.2%

ABSI
Absci

Biotechnology
AI,Antibody,Therapeutics,Preclinica..

639M

29.7%

-

-0.51%

-

-16.7%

GLUE
Monte Rosa

Biotechnology
MRT-2359, MRT-6160, MRT-8102, CDK2

621M

67.1%

-

7.34%

25.8

18.9%

ESPR
Esperion

Biotechnology
Cholesterol-Lowering Tablets

614M

52.7%

-

-37.4%

-

12.4%

KALV
Kalvista

Biotechnology
Plasma Kallikrein Inhibitors, Oral

603M

47.2%

-

42.1%

-

-17.4%

MLTX
MoonLake

Biotechnology
Sonelokimab, Tri-Specific

596M

29.0%

-

14.2%

-

-82.4%

RGNX
Regenxbio

Biotechnology
Gene,Therapy,AAV,Platform,Pipeline

593M

23.3%

-

-21.4%

-

22.2%

MBX
MBX Biosciences

Biotechnology
Hypoparathyroidism, Hypoglycemia

591M

36.1%

-

19.8%

-

-17.5%

CRVS
Corvus

Biotechnology
Kinase Inhibitor, Adenosine

572M

33.2%

-

41.7%

-

-25.7%

VSTM
Verastem

Biotechnology
Avutometinib, Defactinib

567M

40.8%

-

42.0%

-

108%

BCYC
Bicycle

Biotechnology
Bicycle, Conjugate, Nectin-4

563M

38.9%

-

-81.0%

-

-69.3%

OLMA
Olema

Biotechnology
Palazestrant, OP-3136, KAT6

562M

33.4%

-

15.4%

-

-36.4%

GOSS
Gossamer Bio

Biotechnology
Seralutinib, GB002, PAH Therapy

529M

34.2%

-

-9.70%

-

128%

PRTA
Prothena

Biotechnology
Neurodegeneration, Antibody

529M

58.7%

-

-75.0%

-

-51.1%

Stocks & ETFs Screener: 200+ results (Biotechnology)

Basic Filter

Fundamental Filter

Benchmark

Performance/Technical